Skip to content

Study on the mechanism of electroacupuncture intervention in pain of primary osteoporosis based on rs-fMRI

Study on the mechanism of electroacupuncture intervention in pain of primary osteoporosis based on rs-fMRI

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075736
Enrollment
Unknown
Registered
2023-09-14
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoporosis

Interventions

Control group:Oral calcic D
Experimental group:Oral calcic D+ electroacupuncture therapy

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of the disease; ?Lumbar and back pain, and VAS score: 3-7 points; ? Age 50-75 years old; ? Volunteers to fill in informed consent and agree to participate in clinical trials.

Exclusion criteria

Exclusion criteria: ? Patients with secondary osteoporosis such as hyperthyroidism, rheumatoid arthritis and multiple myeloma; ? Fresh vertebral compression fractures in the last 3 months; ? History of taking anti-osteoporosis drugs in the past 6 months ?Patients with lumbar disc herniation, lumbar stenosis, lumbar tuberculosis and other lumbar diseases; ?Patients with serious primary diseases of cardiovascular, cerebrovascular, liver, kidney, hematopoietic system or systemic multiple organ failure. ? head motion amplitude greater than 2mm; ? There are contraindications in fMRI detection.

Design outcomes

Primary

MeasureTime frame
short-form of McGill pain questionnaire;

Secondary

MeasureTime frame
Oswestry Disability Index; rs-fMRI data acquisition;analgesic consumption;Lumbar joint range of motion;

Countries

China

Contacts

Public ContactXU Daoming

Jiangsu Province Traditional Chinese Medicine Hospital

xudaoming@126.com+86 138 1401 9178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026